HRT Financial’s Medicines Co MDCO Stock Holding History

HRT Financial’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,071	Closed	-$553K	–	1885
2019 Q3	$553K	Buy	+11,071	New	+$442K	0.03%	630
2019 Q1	–	Sell	-17,202	Closed	-$329K	–	895
2018 Q4	$329K	Buy	+17,202	New	+$400K	0.05%	324

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

HRT Financial's MDCO Position: Q4 2019 in Review

HRT Financial sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 11,071 shares — an estimated $553K sold.

HRT Financial first reported a position in MDCO in Q4 2018 and held it in 2 quarters. The position peaked at $553K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

HRT Financial reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
HRT Financial sold 11,071 Medicines Co shares in Q4 2019, an estimated $553K.
HRT Financial first reported a position in Medicines Co in Q4 2018 and held it in 2 quarters.
HRT Financial's Medicines Co position peaked at $553K in Q3 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on HRT Financial's 13F filing for Q4 2019, filed 14 Feb 2020.